
Arcturus-Delaware (the “Exchange Agreement”). We are issuing this opinion in connection with the registration statement on FormS-4, which includes the joint proxy statement/prospectus, filed with the Securities and Exchange Commission (the “Commission”) on April 11, 2019 (as filed and amended, the “Registration Statement”).
As set out in the Registration Statement, the Scheme of Arrangement shall include a transfer of all outstanding securities of the Company to Arcturus-Delaware in exchange for newly issued securities of Arcturus-Delaware, on aone-for-one basis. In addition, the Scheme of Arrangement may include a transfer by the Company to Arcturus-Delaware of all of the shares of Arcturus Therapeutics, Inc., a Delaware corporation (“Private Arcturus”), so that Private Arcturus will become a directly held, wholly-owned, subsidiary of Arcturus-Delaware.
For purposes of the opinion set forth below, we have relied, with the consent of each of the Company, Arcturus-Delaware and Private Arcturus, upon the accuracy and completeness of the factual statements and representations that are contained in the Exchange Agreement, the Registration Statement, including the joint proxy statement/prospectus that forms a part of the Registration Statement, certificates of officers of the Company and Private Arcturus, and such other records, documents, and information as in our judgment are necessary or appropriate to enable us to provide such opinion.
We have not undertaken any independent investigation of any factual matter set forth in any of the foregoing, and we have assumed that (i) such factual statements and representations are accurate and complete as of the date hereof and will be accurate and complete as of the effective time of the Scheme of Arrangement, (ii) the factual statements and representations made to the knowledge of any person or entity or with similar qualification are and will be true and correct as if made without such qualification, (iii) the Scheme of Arrangement will be consummated in the manner contemplated by, and in accordance with, the terms set forth in the Exchange Agreement and described in the Registration Statement, without the waiver of any material condition, and (iv) the Scheme of Arrangement will be effective under applicable Israeli law.
Subject to the assumptions, qualifications and limitations set forth herein and in the Registration Statement, we hereby confirm that the discussion in the Registration Statement under the heading “Certain Material Israeli Tax Consequences of the Transaction” fairly summarizes the matters described therein in our opinion insofar as such discussion relates to matters of the Israeli Income Tax Ordinance (New Version), 1961 and legal conclusions with respect to those matters.
No opinion is expressed on any matters other than those specifically covered by this opinion, and accordingly - except as expressly set forth above, we express no opinion to any party as to any tax consequences, whether of the Scheme of Arrangement or of any transaction related to or contemplated by the Scheme of Arrangement.
This opinion is expressed as of the date hereof and is based on provisions of the Israeli Income Tax Ordinance (New Version), 1961, and any regulations, rules, orders or procedures promulgated thereunder, published rulings of the Israeli Tax Authority, and case law, in each case as in effect as of the date hereof, any of which may be changed at any time with retroactive effect. Any change in applicable laws or facts or in circumstances surrounding the Scheme of Arrangement, or any inaccuracy in the statements, facts, assumptions, and representations upon which we have relied, may affect the validity of our opinion. In addition, our opinion is based on the assumption that the matters will be properly presented to the applicable court. Further, our opinion is not binding on the Israeli Tax Authority or a court. There can be no assurance that the Israeli Tax Authority will not take contrary positions or that a court would agree with our opinion if litigated.
-2-